Analytical Data
-
基因名
EIF3M
- Application
-
别名
PCID1; HFLB5; GA17; eIF3m; hfl-B5; PCI Domain Containing 1; Herpesvirus Entry Mediator; Fetal lung protein B5; PCI domain-containing protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7L2H7
-
表达区间
Ser2~Ser251
-
分子量
31.7kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EIF3M, or Eukaryotic Translation Initiation Factor 3 Subunit M, is a vital component of the eukaryotic translation initiation complex and plays a crucial role in the regulation of protein synthesis. Research into EIF3M has gained prominence due to its involvement in various cellular processes, including cell growth, differentiation, and response to stress. Alterations in EIF3M expression levels have been associated with several diseases, particularly cancer, where it may affect tumor progression and metastasis by influencing the translation of specific oncogenes and tumor suppressor genes. Understanding the structure and function of recombinant EIF3M protein can provide insights into its mechanistic role in translation initiation and its potential as a therapeutic target. Furthermore, advances in recombinant DNA technology have enabled the production of purified EIF3M, facilitating detailed biochemical and biophysical characterization. Investigating EIF3M's interactions with other translation factors and its contribution to ribosome assembly is crucial for elucidating the complexities of protein synthesis regulation. Overall, the study of EIF3M as a recombinant protein holds significant promise for uncovering its roles in cellular physiology and disease, potentially leading to innovative strategies for diagnosis and treatment.
